ArticleJournal of medical systems2026
Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.
Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Identifying risk factors for osteoradionecrosis of the jaws: a systematic review and meta-analysis.Clinical oral investigations · 2026Pooled it
- Personalized Prevention of Osteoradionecrosis of the Jaws: From Clinical Risk Profiling and Site-Specific Dosimetry to Artificial Intelligence and Individualized Treatment-Effect Estimation.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
To develop and validate predictive models for osteoradionecrosis (ORN) after head and neck radiation therapy (RT) using time-to-event data with death as the competing risk, and to quantify the degree of risk overestimation when the competing risk is ignored. In this prognostic study of patients who underwent curative RT between 2011 and 2018, with ongoing follow-up, sociodemographic, clinical, and dosimetric data were collected. The binary ORN outcome was defined by the ClinRad system (grade ≥ 1); all-cause mortality was the competing event. Fine-Gray regression (FGR), Random Survival Forests (RSF) with Gray's test splitting rule, and DeepHit were implemented using repeated nested stratified cross-validation. Feature selection and interpretation were guided by SHapley Additive exPlanations (SHAP). For comparison, non-competing risk models such as Cox proportional hazards (Cox PH) and standard RSF (S-RSF) with log-rank splitting rule were also trained. Of 2,466 patients, 183 developed ORN during follow-up, and 714 died. Three versions of each model were developed using 20, 10, and 5 features. The 10- and 5-feature RSF models performed best. Considering simplicity, the 5-feature model, which included tumor site, D10cc, smoking pack-years, periodontal condition, and dental insurance, was selected for production. At 60 months, Brier Score was 0.061 (95% CI: 0.060-0.063), Integrated Brier Score 0.038 (95% CI: 0.037-0.040), time-dependent AUC 0.776 (95% CI: 0.762-0.789), and C-index 0.772 (95% CI: 0.757-0.787). FGR closely followed, whereas DeepHit underperformed. Non-competing models, including the S-RSF, overestimated ORN risk, predicting an average 60-month cumulative incidence of 8.7% versus 6.8% with the 5-feature RSF. A parsimonious RSF model reliably estimated individualized ORN risk while avoiding overestimation from ignored competing risks. An interactive web application was developed to support clinical implementation.
Indexed as
Identifiers
41801474What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.